RENEW ENERGY GLOBAL PLC (RNW): what the price assumes

boothcheck covers RENEW ENERGY GLOBAL PLC (RNW) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-06-28.

Generated: 2026-09-27 · Source: https://boothcheck.com/report/RNW

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

How unusual the bet is: n/a

Valuation X-Ray

Only the growth-DCF reaches the price among the applicable families; asset-based and earnings-power and relative-multiple land below it.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that justify the price: Growth Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 4.5%); the inversion above states its own rate.

Per-Model Detail (n=14)

Solvency

Bullet Takeaways

• ReNew Energy Global is one of India's largest renewable power producers, building and operating solar and wind capacity under long-term contracts, so its value is the cash flow from a growing fleet of generating assets rather than near-term accounting profit.
• The single most decisive number is operating capacity: the portfolio reached 12.8 GW, up 25 percent year over year, and the company is moving upstream into solar-cell manufacturing, so the rate of profitable capacity addition drives the entire thesis.
• The defining risk is the debt: building power plants is capital-heavy, and the company carries multi-billion-dollar net debt against thin accounting operating income, so the bet depends on rising EBITDA outpacing the interest and on continued access to capital.

Bull Case

The number that anchors the bull case is capacity, because for a renewable power producer installed gigawatts are the asset that compounds. ReNew's operating portfolio reached 12.8 GW, a 25 percent increase year over year, with 2.4 GW of new capacity commissioned in the most recent fiscal year. Each gigawatt comes with long-term power-purchase contracts that turn sunshine and wind into contracted, inflation-resistant cash flow for decades. A company adding capacity at a double-digit annual rate in a country with India's structural demand for power is building an annuity stream that the current accounting earnings, depressed by the heavy depreciation and interest that come with new assets, do not yet reflect.

The financial trajectory is bending the right way. Fiscal 2026 revenue grew 36 percent to roughly ₹132 billion, net income rose 162 percent to about ₹10 billion, and adjusted EBITDA, the measure that matters for a capital-intensive utility, grew 31 percent to roughly ₹75 billion, above the company's prior guidance. Crucially, leverage declined even as the fleet grew, and management raised its EBITDA outlook for the next fiscal year. Rising EBITDA with falling leverage is the combination that de-risks a debt-funded infrastructure builder: the cash flow that services and reduces the debt is growing faster than the debt itself.

The strategic move upstream adds a second growth lever. ReNew is building toward an additional 4 GW of solar-cell manufacturing capacity, which would let it capture more of the value chain and reduce dependence on imported components, a meaningful edge as India pushes domestic content in renewables. The valuation methods reflect a business priced well below the cash flow its assets can generate: the relative-multiple and forward-growth methods land at or above the price, and a free-cash-flow lens reads the stock as inexpensive relative to the cash the fleet throws off. For an investor who can underwrite the debt and the execution, a leading position in one of the world's largest renewable-energy build-outs, with EBITDA rising and leverage falling, is the growth-infrastructure bet the bull case rests on.

Bear Case

The plain truth a holder has to confront is how little accounting profit sits beneath this price relative to how much debt does. ReNew earns a return on equity of only about 3.5 percent, and its trailing operating income is a thin sliver against net debt of roughly $7 billion, so the conventional coverage and leverage measures are stretched to the point of being alarming on their face. Building power plants consumes capital years before the cash flow arrives, which is the nature of the business, but it also means the equity is a thin, highly geared claim sitting on top of a very large debt stack. If the cost of that debt rises, or if EBITDA growth stalls, the equity bears the squeeze first and hardest.

The valuation, read honestly, is demanding once the asset-based lens is taken seriously. The asset-based and earnings-power methods read the stock as expensive, because on book value and normalized earnings the business is not yet creating value above its cost of capital, earning a return well below the roughly 9 percent that capital costs. On company-wide operating income the price implies growth held at the self-funding ceiling for years, a pace only about a third of comparable fast-growers have sustained. The bull leans on EBITDA and capacity; the bear points out that EBITDA is not free cash flow when a company is plowing every rupee back into new plants and servicing a heavy debt load, and that the gap between reported EBITDA and what reaches equity holders is exactly where capital-intensive growth stories disappoint.

The operating risks are real and largely external. Management itself has flagged grid-expansion delays, project curtailments, and demand-side regulations as ongoing risks, all of which can strand or slow the very capacity the thesis depends on; a plant that cannot evacuate its power to the grid earns nothing while still carrying its debt. India's renewable build-out is also competitive and policy-sensitive, with tariffs set in auctions that can compress returns. Layer the leverage, the sub-cost-of-capital return, the dependence on continued capital access, and the regulatory and grid risks, and the price asks the buyer to underwrite a long, clean, debt-funded expansion in an emerging market, with little accounting earnings to cushion a misstep.

Valuation

ReNew is a capital-intensive renewable power producer, and the right lens is the cash flow and EBITDA of its generating fleet, not its accounting operating income. On that operating-income basis the price looks extreme, implying growth held at the self-funding ceiling for years, but that is partly an artifact of how much depreciation and interest a young, fast-growing asset base carries; the more telling measures are the 12.8 GW of operating capacity and the roughly ₹75 billion of adjusted EBITDA that grew 31 percent in the latest year.

The methods split exactly as they do for a leveraged infrastructure builder. The asset-based and earnings-power methods read the price as expensive, because the business earns a return on equity around 3.5 percent, below its cost of capital on current book economics. The relative-multiple and forward-growth methods reach the price, crediting the capacity growth and the EBITDA trajectory, and a free-cash-flow lens reads the stock as inexpensive on the cash the fleet generates. The disagreement is the whole question: value ReNew on what it earns today and it looks rich; value it on the contracted cash flow of a growing asset base and it looks cheap.

Solvency is where the caution must live, and it is not optional for this name. Net debt is roughly $7 billion against thin trailing operating income, so the conventional coverage ratios are deeply stretched, and the equity is a geared claim on the spread between rising EBITDA and a heavy interest bill. The mitigant the company points to is that leverage is declining even as capacity grows, and EBITDA is rising faster than debt; the risk is that any interruption to that trajectory, from grid delays, curtailment, or higher funding costs, falls on the equity first. The price is underwriting that the EBITDA-up, leverage-down path continues long enough for the contracted cash flows to validate the asset base.

Catalysts

Fiscal 2026 was a record year for the operating business. ReNew reported revenue of roughly ₹132.2 billion, up 36 percent year over year, net income of about ₹10.4 billion, up 162 percent, and adjusted EBITDA of roughly ₹74.8 billion, up 31 percent and above prior guidance. The operating portfolio grew 25 percent to 12.8 GW, with 2.4 GW of new capacity commissioned during the year.

The forward catalysts are capacity, manufacturing, and deleveraging. The company plans to add about 4 GW of solar-cell manufacturing capacity by December 2026, moving upstream in the value chain, and management raised its EBITDA projection for the next fiscal year while targeting further leverage reduction. Management also flagged ongoing risks from grid-expansion delays, project curtailments, and demand-side regulations. The signals to track are the pace of profitable capacity commissioning, progress on the manufacturing ramp, and continued reduction in net debt-to-EBITDA, the three measures that determine whether the contracted cash flows grow into the debt the equity sits above.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

• WD (Walker & Dunlop, Inc.)
• FY2025 10-K: …loan carries an interest rate of SOFR plus 1.87 % and will require our subsidiary to make insignificant monthly principal payments until October 1, 2029 at which point the subsidiary will make a $ 33.1 million principal payment. ​ ​ ​ NOTE 17-OTHER REVENUES, OTHER OPERATING EXPENSES, AND ASSET IMPAIRMENTS AND OTHER…
• FY2025 10-K: 41) ​ 37 % Principal collected on loans held for investment ​ - ​ 55,701 ​ (55,701) ​ (100) ​ Purchases of pledged AFS securities, net of proceeds from prepayments ​ ​ (20,366) ​ ​ (41,857) ​ ​ 21,491 ​ (51) ​ Originations and repurchase of loans held for investment ​ ​ (24,381) ​ ​ (37,928) ​ ​ 13,547 ​ (36) ​ Other…
• STRA (Strategic Education, Inc.)
• FY2025 10-K: $112.7 million in 2024 compared to $69.8 million in 2023 due to the factors discussed above. Non-GAAP Financial Measures We use certain financial measures including Adjusted Total Costs and Expenses, Adjusted Income from Operations, Adjusted Operating Margin, Adjusted Income Before Income Taxes, Adjusted Net Income,…
• FY2025 10-K: …learning modalities, we face increasing competition for students from traditional colleges, including colleges with well-established reputations for excellence and colleges in states that offer various forms of "free college" programs. As online learning matures as a modality for education delivery across higher…
• PGNY (Progyny, Inc.)
• FY2025 10-K: …profit and gross margin will continue to be affected by various factors including the geographic location where treatments are performed, as well as pricing with each of our clients, provider clinics, labs, specialty pharmacies and pharmaceutical companies, all of which are negotiated separately, have different…
• FY2025 10-K: …10-K and our other filings with the U.S. Securities and Exchange Commission, or the SEC, before making an investment decision regarding our common stock. • We may fail to meet our publicly announced guidance or other expectations about our business and future results of operations, which would cause our stock price…
• AM (ANTERO MIDSTREAM CORPORATION)
• FY2025 10-K: …basis. (2) Amounts include charges for accretion of asset retirement obligations, loss on settlement of asset retirement obligations and loss (gain) on sale of assets, as applicable, which represent segment operating expenses that are not considered significant . ​ F-32 Table of Contents ANTERO MIDSTREAM CORPORATION…
• FY2025 10-K: Other assets, net ​ ​ 476 ​ Total ​ $ 383,636 ​ ​ ​ ​ ​ ​ Current liabilities: ​ ​ ​ ​ Accounts payable-third party ​ $ 634 ​ Accrued liabilities ​ ​ 1,663 ​ Long-term liabilities: ​ ​ ​ ​ Other long-term liabilities ​ ​ 3,021 ​ Total ​ $ 5,318 ​ ​ ​ (4) Intangibles All customer relationships are subject to…
• NPO (NPO)
• FY2025 10-K: …or service capacity, our customers may divert their purchases of products and services from us to our competitors. We may not have sufficient resources to continue to make such investments or maintain our competitive position. Additionally, some of our competitors are larger than we are and have substantially greater…
• FY2025 10-K: …In addition, in the past, we have experienced downturns in end-market demand due to uncertainty regarding the impact of tariffs or threatened tariffs and related trade tensions. The United States and other countries have imposed and may continue to impose new trade restrictions and export regulations, have levied…
• AIN (AIN)
• FY2025 10-K: …business plan values with Safran for the subsequent full twelve-month calendar year. Orders included in our backlog may be modified, canceled, or rescheduled by our customers, although customers may incur cancellation penalties as defined in the terms of such customer contracts; and which such terms may vary from…
• FY2025 10-K: …and lower than anticipated sales pricing. This decline is slightly offset by a strong performance within the European market, particularly related to the drying and pressing programs. Further, changes in currency translation rates had the effect of increasing Net revenues $1.2 million. Gross Profit Gross profit…
• AVO (AVO)
• FY2025 10-K: …rates between the U.S. dollar and these local currencies usually do not have a significant impact on our gross margin because the impact typically affects our pricing by comparable amounts. Our margin exposure to exchange rate fluctuations is short-term in nature, as our sales price commitments are generally limited…
• FY2025 10-K: …its Marketing & Distribution segment during the first quarter of 2025. In connection with the closure, we recognized approximately $2.7 million in charges for fiscal 2025. Charges consisted of accelerated depreciation expense of property, plant and equipment, accelerated amortization expense of operating lease…
• SHC (SHC)
• FY2025 10-K: …other end-users of such devices might decrease their use of such devices in favor of reusable medical products, which would decrease the demand for our services, which could in turn have a material adverse effect on our business, prospects, financial condition or results of operations. Our business is highly…
• FY2025 10-K: …Contents Government or private civil antitrust actions could harm our business, prospects, financial condition or results of operations. The antitrust laws prohibit a wide variety of conduct that unlawfully suppresses competition, such as conspiracies among competitors not to reduce (or to "fix") prices. Although our…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.